Citation:Gerson LB, Groeneveld PW, Triadafilopoulos G 2004

From Cancer Guidelines Wiki

Citation


Gerson LB, Groeneveld PW, Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2004 Oct;2(10):868-79 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15476150.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
How effective is endoscopic management compared with surgical management for high grade dysplasia in patients with BO?Associate Professor Bernard Mark Smitherscompleted
For which populations is screening for BO cost-effective?Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhilcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:How effective is endoscopic management compared with surgical management for high grade dysplasia in patients with BO?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:How effective is endoscopic management compared with surgical management for high grade dysplasia in patients with BO?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For which populations is screening for BO cost-effective?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For which populations is screening for BO cost-effective?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. For which populations is screening for BO cost-effective?